Joining the IMA Leadership Team during the COVID-19 Pandemic

By Michele Aguirre, Regional Director of Clinical Operations, IMA Clinical Research

I joined IMA in March 2020 as the Regional Director for Clinical Operations during a turning point in history, the COVID-19 pandemic.  I have been working in the field of clinical research for over 20 years and love that I am part of something that has the ability to impact lives by developing future medications. Most of my career in clinical research has been on the clinical operations side, but I did spend a few years working in regulatory and quality assurance roles.  I started my research career path as a study coordinator and then moved through various leadership positions within the industry. 

Joining the IMA group during this time has really impressed me as our organization really put patients first by designing safe ways for our patients to continue to get access to healthcare and for our research patients continue their current study participation. COVID-19 has brought us many operational challenges in our organization but we have worked as a team to create processes that minimize the impact at our research sites/facilities.  This includes policies and procedures that screen for COVID-19, enhanced cleaning and disinfecting protocols, and virtual appointments when possible to promote the health and safety of our study participants and staff.

We continue to communicate with our on-trial and potential volunteers and are providing them with information about how they can stay safe and healthy during this time. We are also preparing them for what to expect when they visit our facilities, given our enhanced screening and safety measures. Our employees receive frequent updates on the COVID-19 situation.

At IMA our priority remains to keep our volunteers and employees safe and well-informed while doing what we can to help minimize the potential spread of the coronavirus. We will continue to dedicate significant resources and efforts to mitigate the risks while still ensuring business continuity to the greatest extent possible.